Alexion Pharma (Switzerland)

Alexion Pharma (Switzerland)

Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

53%


Total
Publications

90


Total Open
Publications

48


Total
Citations

1.2K


Open Access
Percentage

53%


Total
Publications

90


Total Open
Publications

48


Total
Citations

1.2K

Wikipedia

Website

download

Breakdown

23% 28% 2% 47%

Publisher Open

23%

Both

28%

Other Platform Open

2%

Closed

47%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

41%OA Journal

OA Journal 41%

19

Hybrid 28%

13

No Guarantees 31%

14

Other Platform Open

Domain 78%

21

Institution 52%

14

Preprint 4%

1

Public 4%

1

Other Internet 4%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
21
Europe PMC
Domain
13
Ghent University - Ghent University Academic Bibliography
Institution
8
Radboud University - Radboud Repository
Institution
4
Newcastle Univesity - Newcastle University ePrints
Institution
3
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
3
University of Geneva - Archive ouverte UNIGE
Institution
2
Université de Lausanne - SERVAL
Institution
1
University of Melbourne - Minerva Access
Institution
1
University of Liège - ORBi - Open Repository and Bibliography of the University of Liège
Institution
1
1 / 2

Data updated 14 March 2024

Share

Share

Share